Newsroom
All news
Press releases, scientific publications and media coverage from Auxilius Pharma
Recent Publications
16 publications
May 2026
Unlocking the Full Potential of Global Drug Innovation Through the FDA's 505(b)(2) Pathway
International Clinical Trials – Spring 2026 edition
December 3, 2025
Auxilius Pharma Announces USD 4 Million Series A Financing Round to Advance Development of AUX-001 for Chronic Stable Angina
November 17, 2025
NanoGroup acquired a stake in Auxilius Pharma for PLN 7.5 million and entered the VAM segment
July 7, 2025
Chronic angina costs more than you think
November 11, 2024
PharmaShots CXO Talks interview with Auxilius Pharma’s CEO Jed Litwiniuk, MHA, and CMO, Uwe Tigor, MD
September 2, 2024
AUX-001 Phase 1a results presented at European Society of Cardiology annual meeting 2024
June 17, 2024
Auxilius has started thinking about the stock exchange
June 5, 2024
CSAP Management: Uwe P Tigör from Auxilius Pharma in Conversation with PharmaShots
March 27, 2024
Auxilius Pharma to launch Phase 1b anti-anginal trial after IND application
March 15, 2024
Media Release: Pioneering Progress: Auxilius Pharma's AUX-001 Delivers Positive First-in-Human Pharmacokinetic & Safety Results in Anti-Anginal R&D
March 15, 2024
Angina: Auxilius Pharma Announces Successful Conclusion of First-in-Human Clinical Trial of AUX-001 for Treatment of Chronic Stable Angina Pectoris
March 15, 2024
FirstWord Pharma: Pioneering Progress, Auxilius Pharma's AUX-001 Delivers Impressive First-in-Human Pharmacokinetic and Safety Results in Anti-Anginal R&D
January 26, 2023
Americans have Silicon Valley, Poland a biotech valley — cooperation with global giants is bearing fruit
November 4, 2022
Auxilius sees a business in transferring generics
March 9, 2021
